PBYI - Puma Biotechnology Q4 2022 Earnings Preview
- Puma Biotechnology ( NASDAQ: PBYI ) is scheduled to announce Q4 earnings results on Thursday, March 2nd, after market close.
- The consensus EPS Estimate is $0.10 (-52.4% Y/Y) and the consensus Revenue Estimate is $57.06M (+3.0% Y/Y).
- Over the last 2 years, PBYI has beaten EPS estimates 75% of the time and has beaten revenue estimates 75% of the time.
For further details see:
Puma Biotechnology Q4 2022 Earnings Preview